REAL-WORLD USE OF TAFASITAMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES BY PRIMARY REFRACTORY STATUS K Saverno; KMZ Savill; B Feinberg; J Galvin; P Pathak; T Amoloja; N Epperla; LJ Nastoupil;

REAL-WORLD SEQUENTIAL USE OF CD19-DIRECTED THERAPIES FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: TAFASITAMAB PRECEDING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY N Epperla; LJ Nastoupil; B Feinberg; J Galvin; P Pathak; T Amoloja; D Gentile; K Saverno;